Hims & Hers Revenue Jumps 49% but Company Cuts Full-Year EBITDA Outlook
Hims & Hers Health said Monday its third-quarter revenue rose 49% to $890.4 million, driven by a more than fourfold jump outside the U.S., but the telehealth company lowered its full-year profit outlook as it spends ahead of planned expansions, according to its earnings release.
The company cut its 2026 adjusted EBITDA forecast to $257 million to $277 million and tightened revenue guidance to $3.13 billion to $3.15 billion. For the fourth quarter it expects revenue of $875 million to $895 million and adjusted EBITDA of $70 million to $90 million.
Hims & Hers swung to a net loss of $33.0 million from net income of $15.8 million a year earlier. Gross margin fell to 57% from 74%. Adjusted EBITDA rose to $82.4 million from $78.4 million.
Growth abroad
U.S. revenue grew 21% to $657.1 million, while revenue from the rest of the world rose 321% to $233.3 million. Subscribers climbed 13% to 2,788,000, and monthly revenue per average subscriber increased to $105 from $81.
Chief Financial Officer Yemi Okupe said the company was "intentionally pacing marketing spend ahead of several planned expansions to our platform in the fourth quarter." Free cash flow fell to $26.0 million from $79.4 million.
New director
In a separate 8-K, the company said its board expanded to 10 members from nine on Nov. 4 and appointed Dr. Andrew Huberman as a director. The board determined he does not meet New York Stock Exchange independence requirements, and he is not expected to join any committee.
Huberman will receive a $50,000 annual cash retainer and an annual equity award valued at $250,000, both prorated through the 2027 annual meeting, according to the filing.
By the numbers
- Q3 revenue: $890.4 million, up 49%
- Subscribers: 2,788,000, up 13%
- Net loss: $33.0 million
- Adjusted EBITDA: $82.4 million
- 2026 adjusted EBITDA outlook: $257 million to $277 million
Sources
- Form 8-K with Exhibit 99.1 earnings release, Hims & Hers Health, Inc., filed Nov. 9, 2026, accession 0001773751-26-000242
- Form 8-K (Item 5.02), Hims & Hers Health, Inc., filed Nov. 9, 2026, accession 0001773751-26-000245
This article is for informational and educational purposes only and is not investment advice. It is not a recommendation to buy or sell any security.
Disclaimer: This article was generated by IDD’s autonomous newsroom using super intelligence. SI may make mistakes.